Literature DB >> 11761841

[An epidemiologic survey of multiple sclerosis in the Szczecin province in Poland].

A Potemkowski.   

Abstract

The possibility of a focus of the province of Szczecin (Northwestern part of Poland) was first noticed in our survey covering the period of 1960-86. Starting from 1986 the incidence of MS in this region was closely followed. Seven communes with an area of 1202 km2 and 45,231 inhabitants, had 50 MS patients on Dec. 31st, 1995 and a prevalence rate of 110,54/100,000. This is twice the prevalence more than in surrounding area (52,89/100,000). New cases appeared irregularly, with four peaks in 1960, 1967-8, 1976-7 and 1981-2. The age at onset, duration of disease, life expectancy and natural history of the disease in the focus and rest of Szczecin region were similar. We conclude, that clustering seems to be due to the influence of environmental factors, such as peat soil, coniferous forest, quality of drinking water and nearby industrial plants.

Entities:  

Mesh:

Year:  2001        PMID: 11761841

Source DB:  PubMed          Journal:  Przegl Epidemiol        ISSN: 0033-2100


  3 in total

1.  Effect of Whole-Body Cryotherapy on Morphological, Rheological and Biochemical Indices of Blood in People with Multiple Sclerosis.

Authors:  Bartłomiej Ptaszek; Aneta Teległów; Justyna Adamiak; Jacek Głodzik; Szymon Podsiadło; Dawid Mucha; Jakub Marchewka; Tomasz Halski; Dariusz Mucha
Journal:  J Clin Med       Date:  2021-06-27       Impact factor: 4.241

2.  Prevalence and incidence of multiple sclerosis in central Poland, 2010-2014.

Authors:  Waldemar Brola; Piotr Sobolewski; Stanisław Flaga; Małgorzata Fudala; Wiktor Szczuchniak; Jan Stoiński; Anita Rosołowska; Jacek Wójcik; Katarzyna Kapica-Topczewska; Danuta Ryglewicz
Journal:  BMC Neurol       Date:  2016-08-11       Impact factor: 2.474

3.  Self-reported quality of life in multiple sclerosis patients: preliminary results based on the Polish MS Registry.

Authors:  Waldemar Brola; Piotr Sobolewski; Małgorzata Fudala; Stanisław Flaga; Konrad Jantarski; Danuta Ryglewicz; Andrzej Potemkowski
Journal:  Patient Prefer Adherence       Date:  2016-08-26       Impact factor: 2.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.